Hepatitis B and C management in context of newer therapies
HBV vs HCV side by side
The exam tests the two viruses side by side. The single most important contrast:
| HBV | HCV | |
|---|---|---|
| Genome | Partially dsDNA, cccDNA + integration | ssRNA, cytoplasmic only |
| Curable? | No - suppression only | Yes - >95% SVR |
| Endpoint | HBsAg loss ("functional cure", ~1%/yr) | SVR12 |
| Therapy | Indefinite nucleos(t)ide analogue | 8-12 weeks oral DAA |
| Vaccine | Yes | No |
| HCC without cirrhosis | Yes (~20%) - integration | Essentially no |
| Post-cure surveillance | Continue if male >40 / female >50 at clearance | Only if cirrhotic at cure |
14 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access